Update on bone health: the International Menopause Society White Paper 2021

References

• Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17:1726–1733.
   PubMed Web of Science ®Google Scholar
• Kanis, J.A, Odén A, McCloskey EV, et al. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int. 2012;23:2239–2256.
   PubMed Web of Science ®Google Scholar
• Bliuc D, Nguyen ND, Milch VE, et al. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA. 2009;301:513–521.
   PubMed Web of Science ®Google Scholar
• Consensus development conference: Prophylaxis and treatment of osteoporosis. JAMA. 1991;90:107–110.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Oden A, Johnell O, et al. The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int. 2001;12:417–427.
   PubMed Web of Science ®Google Scholar
• Balasubramanian A, Zhang J, Chen L, et al. Risk of subsequent fracture after prior fracture among older women. Osteoporos Int. 2019;30:79–92.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Johansson H, Odén A, et al. Characteristics of recurrent fractures. Osteoporos Int. 2018;29:1747–1757.
   PubMed Web of Science ®Google Scholar
• Johansson L, Sundh D, Magnusson P, et al. Grade 1 vertebral fractures identified by densitometric lateral spine imaging predict incident major osteoporotic fracture independently of clinical risk factors and bone mineral density in older women. J Bone Miner Res. 2020;35:1942–1951.
   PubMed Web of Science ®Google Scholar
• Adult Official Positions of the ISCD as updated in 2019. www.iscd.org. Last assessed July 2021.
   Google Scholar
• Camacho P, Petak SM, Brinkley N, et al. American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis – 2020 update. Endocr Pract. 2020;26(Suppl 1).
   Google Scholar
• Eastell R, Rosen CJ, Black DM, et al. Pharmacological management of osteoporosis in postmenopausal women: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2019;104:1595–1622.
   PubMed Web of Science ®Google Scholar
• Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA. 1998;280:2077–2082.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Johansson H, Harvey NC, et al. A brief history of FRAX. Arch Osteoporos. 2018;13(1):118.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Harvey NC, Cooper C, et al. Advisory Board of the National Osteoporosis Guideline Group. A systematic review of intervention thresholds based on FRAX. Arch Osteoporos. 2016;11:25.
   PubMed Web of Science ®Google Scholar
• Clark P, Denova-Gutiérrez E, Zerbini C, et al. FRAX-based intervention and assessment thresholds in several Latin American countries. Osteoporos Int. 2018;29:707–715.
   PubMed Web of Science ®Google Scholar
• Silva B, Leslie W. Trabecular bone score: A new DXA-derived measurement for FRAX risk assessment. Endocrinol Metab Clin North Am. 2017;46:153–180.
   PubMed Web of Science ®Google Scholar
• Masud T, Binkley N, Boonen S, et al. Official Positions for FRAX(R) clinical regarding falls and frailty: can falls and frailty be used in FRAX(R)? From Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®. J Clin Densitom. 2011;14:194–204.
   PubMed Web of Science ®Google Scholar
• Leslie WD, Johansson H, McCloskey EV, et al. Comparison of methods for improving fracture risk assessment in diabetes: The Manitoba BMD Registry. J Bone Miner Res. 2018;33:1923–1930.
   PubMed Web of Science ®Google Scholar
• NATAP. Clinician’s guide to prevention and treatment of osteoporosis (National Osteoporosis Foundation Guidelines). Available at: www.natap.org/2008/HIV/070708_01.htm [Internet]. Accessed May 2021.
   Google Scholar
• Kanis JA, Johansson H, Strom O, et al. The National Osteoporosis Guideline Group. Case finding for the management of osteoporosis with FRAX® – assessment and intervention thresholds for the UK. Osteoporos Int. 2008;19:1395–1408.
   PubMed Web of Science ®Google Scholar
• McCloskey E, Kanis JA, Johansson H, et al. FRAX-based assessment and intervention thresholds–an exploration of thresholds in women aged 50 years and older in the UK. Osteoporos Int. 2015;26:2091–2099.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Harvey NC, McCloskey E, et al. Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Osteoporos Int. 2020;31:1–12.
   PubMed Web of Science ®Google Scholar
• Comston JE, Drake MT. Defining very high fracture risk: is FRAX fit for purpose? J Bone Miner Res. 2020;35:1399–1403.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Cooper C, Rizzoli R, et al. Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019;30:3–44.
   PubMed Web of Science ®Google Scholar
• Baber RJ, Panay N, Fenton A and the IMS Writing Group. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016;19:109–150.
   PubMed Web of Science ®Google Scholar
• De Villiers TJ. The role of menopausal hormone therapy in the management of osteoporosis. Climacteric. 2015;18:19–21.
   PubMed Web of Science ®Google Scholar
• De Villiers TJ, Chines AA, Palacios S, et al. Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial. Osteoporos Int. 2011;22:567–576.
   PubMed Web of Science ®Google Scholar
• Pang KL, Low NY, Chin KY. A review on the role of denosumab in fracture prevention. Drug Des Devel Ther. 2020;14:4029–4051.
   PubMed Web of Science ®Google Scholar
• Bone HG, Wagman RG, Brandi ML, et al. 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. Lancet Diabetes Endocrinol. 2017;5:513–523.
   PubMed Web of Science ®Google Scholar
• Cummings SR, Ferrari S, Eastell R, et al. Vertebral fractures after discontinuation of denosumab: a post-hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension. J Bone Miner Res. 2018;33:190–198.
   PubMed Web of Science ®Google Scholar
• Black DM, Rosen CJ. Postmenopausal osteoporosis. N Engl J Med. 2016;374:254–262.
   PubMed Web of Science ®Google Scholar
• Kendler DL, Marin F, Zerbini CAF, et al. Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO); a multicentre double- blind, double-dummy randomised controlled trial. Lancet. 2018;391:230–240.
   PubMed Web of Science ®Google Scholar
• Saag KG, Petersen J, Brandi ML, et al. Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med. 2017;377:1417–1427.
   PubMed Web of Science ®Google Scholar
• Schapira D, Schapira C. Osteoporosis: The evolution of a scientific term. Osteoporos Int. 1992;2:164–167.
   PubMed Web of Science ®Google Scholar
• Santilli V, Bernetti A, Mangone M, et al. Clinical definition of sarcopenia. Clin Cases Miner Bone Metab. 2014;11:177–180.
   PubMedGoogle Scholar
• Rosenberg I. Summary comments: Epidemiological and methodological problems in determining nutritional status of older persons. Am J Clin Nutr. 1989;50:1231–1233.
   Web of Science ®Google Scholar
• Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletal muscle strength, mass, and quality in older adults: The health, aging and body composition study. J Gerontol A Biol Sci Med Sci. 2006;61:1059–1064.
   PubMed Web of Science ®Google Scholar
• Schneider SM, Al-Jaouni R, Filippi J, et al. Sarcopenia is prevalent in patients with Crohn’s disease in clinical remission. Inflamm Bowel Dis. 2008;14:1562–1568.
   PubMed Web of Science ®Google Scholar
• Anker SD, Morley JE, von Haehling S, et al. Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle. 2026;7(5):512–514.
   Web of Science ®Google Scholar
• Muscaritoli M, Anker SD, Argiles J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by special interest groups (SIG) ‘cachexia-anorexia in chronic wasting diseases’ and ‘nutrition in geriatrics’. Clin Nutr. 2010;29:154–159.
   PubMed Web of Science ®Google Scholar
• Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: An undiagnosed condition in older adults–Current consensus definition: Prevalence, etiology, and consequences. International Working Group on Sarcopenia. J Am Med Dir Assoc. 2011;12:249–256.
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis–report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412–423.
   PubMed Web of Science ®Google Scholar
• Rizzoli R, Reginster JY, Arnal JF, et al. Quality of life in sarcopenia and frailty. Calcif Tissue Int. 2013;93:101–120.
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31.
   PubMed Web of Science ®Google Scholar
• Brinkley N, Buehring B. Beyond FRAX: It's time to consider ‘sarco-osteopenia’. J Clin Densitom. 2009;12:413–416.
   PubMed Web of Science ®Google Scholar
• Drey M, Sieber CC, Bertsch T, et al; FiAT Intervention Group. Osteosarcopenia is more than sarcopenia and osteopenia alone. Aging Clin Exp Res. 2016;28:895–899.
   PubMed Web of Science ®Google Scholar
• Hassan EB, Duque G. Osteosarcopenia: A new geriatric syndrome. Aust Fam Physician. 2017;46:849–853.
   PubMedGoogle Scholar
• Sepúlveda-Loyola W, Phu S, Bani Hassan E, et al. The joint occurrence of osteoporosis and sarcopenia (osteosarcopenia): Definitions and characteristics. J Am Med Dir Assoc. 2020;21:220–225.
   PubMed Web of Science ®Google Scholar
• Kopperdahl DL, Aspelund T, Hoffmann PF, et al. Assessment of incident spine and hip fractures in women and men using finite element analysis of CT scans. J Bone Miner Res. 2014;29:570–580.
   PubMed Web of Science ®Google Scholar
• Kirk B, Miller S, Zanker J, et al. A clinical guide to the pathophysiology, diagnosis and treatment of osteosarcopenia. Maturitas. 2020;140:27–33.
   PubMed Web of Science ®Google Scholar